Dubuque Bank & Trust’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-105
Closed -$8K – 203
2019
Q1
$8K Hold
105
– – ﹤0.01% 497
2018
Q4
$8K Hold
105
– – ﹤0.01% 449
2018
Q3
$8K Hold
105
– – ﹤0.01% 448
2018
Q2
$8K Hold
105
– – ﹤0.01% 477
2018
Q1
$7K Hold
105
– – ﹤0.01% 535
2017
Q4
$7K Hold
105
– – ﹤0.01% 534
2017
Q3
$7K Buy
105
+55
+110% +$3.48K ﹤0.01% 515
2017
Q2
$3K Hold
50
– – ﹤0.01% 561
2017
Q1
$3K Hold
50
– – ﹤0.01% 581
2016
Q4
$3K Hold
50
– – ﹤0.01% 502
2016
Q3
$3K Hold
50
– – ﹤0.01% 482
2016
Q2
$3K Buy
+50
New +$2.9K ﹤0.01% 508
2016
Q1
– Sell
-1,158
Closed -$79K – 615
2015
Q4
$79K Hold
1,158
– – 0.02% 256
2015
Q3
$74K Sell
1,158
-1,260
-52% -$82.9K 0.02% 252
2015
Q2
$154K Hold
2,418
– – 0.03% 226
2015
Q1
$165K Hold
2,418
– – 0.02% 195
2014
Q4
$170K Sell
2,418
-98
-4% -$7.02K 0.03% 178
2014
Q3
$180K Hold
2,516
– – 0.03% 170
2014
Q2
$187K Buy
2,516
+1,516
+152% +$110K 0.03% 194
2014
Q1
$65K Hold
1,000
– – 0.01% 211
2013
Q4
$59K Hold
1,000
– – 0.01% 213
2013
Q3
$52K Hold
1,000
– – 0.01% 214
2013
Q2
$47K Buy
+1,000
New +$50.9K 0.01% 199

Other funds holding AZN

Dubuque Bank & Trust's AZN Position: Q2 2019 in Review

Dubuque Bank & Trust sold out of AstraZeneca (AZN) in Q2 2019, closing a stake of 105 shares — an estimated $8K sold.

Dubuque Bank & Trust first reported a position in AZN in Q2 2013 and held it in 23 quarters. The position peaked at $187K in Q2 2014. 546 funds tracked by Wall St. Rank hold AZN as of Q2 2019.

  • Dubuque Bank & Trust reported no remaining AstraZeneca position as of Q2 2019 after selling out during the quarter.
  • Dubuque Bank & Trust sold 105 AstraZeneca shares in Q2 2019, an estimated $8K.
  • Dubuque Bank & Trust first reported a position in AstraZeneca in Q2 2013 and held it in 23 quarters.
  • Dubuque Bank & Trust's AstraZeneca position peaked at $187K in Q2 2014.
  • 546 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2019.

Based on Dubuque Bank & Trust's 13F filing for Q2 2019, filed 10 Jul 2019.